TrialFind
Saved trials
Back to results
Not yet recruiting
Phase 1
Safety of a Strategy Combining Etanercept Administration with Repeated Contrast Ultrasound in Patients with Alzheimer's Disease
NCT06585384
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Contact
Amélie Yavchitz
+33 1 48 03 64 54
ayavchitz@for.paris
View on ClinicalTrials.gov
Official details
Safety of a Strategy Combining Etanercept Administration with Repeated Contrast Ultrasound in Patients with Alzheimer's Disease — TrialFind